Skip to content
10-K

Annual Report

ACCENDRA HEALTH INC/VA/ ACH

0001104659-26-018169

← back to feed
Filed
Feb 20, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jan 31, 2026 76.44M sh
Shares Diluted FY 2025 · Dec 31, 2025 76.9M sh
Shares Diluted FY 2025 · Dec 31, 2024 76.74M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 77.37M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $10.18M
Capex FY 2025 · Dec 31, 2025 $190.96M
Capex restated FY 2025 · Dec 31, 2024 $170.29M
Capex restated FY 2025 · Dec 31, 2023 $172.38M
Short Term Debt FY 2025 · Dec 31, 2025 $250M
Short Term Debt restated FY 2025 · Dec 31, 2024 $42.87M
Cash And Equivalents FY 2025 · Dec 31, 2025 $281.99M
Cash And Equivalents restated FY 2025 · Dec 31, 2024 $27.57M
Stockholders Equity FY 2025 · Dec 31, 2025 −$460.98M
Stockholders Equity restated FY 2025 · Dec 31, 2024 $586.36M
Stockholders Equity restated FY 2025 · Dec 31, 2023 $945.3M
Stockholders Equity restated FY 2025 · Dec 31, 2022 $966.74M
Current Liabilities FY 2025 · Dec 31, 2025 $947.08M
Current Liabilities restated FY 2025 · Dec 31, 2024 $1.85B
Total Liabilities FY 2025 · Dec 31, 2025 $2.91B
Total Liabilities restated FY 2025 · Dec 31, 2024 $4.07B
Current Assets FY 2025 · Dec 31, 2025 $547.87M
Current Assets FY 2025 · Dec 31, 2024 $2.02B
Total Assets FY 2025 · Dec 31, 2025 $2.45B
Total Assets FY 2025 · Dec 31, 2024 $4.66B
Eps Diluted FY 2025 · Dec 31, 2025 −$14.31
Eps Diluted FY 2025 · Dec 31, 2024 −$4.73
Eps Diluted restated FY 2025 · Dec 31, 2023 −$0.53
Eps Basic FY 2025 · Dec 31, 2025 −$14.31
Eps Basic FY 2025 · Dec 31, 2024 −$4.73
Eps Basic FY 2025 · Dec 31, 2023 −$0.54
Sga Expense FY 2025 · Dec 31, 2025 $1.07B
Sga Expense restated FY 2025 · Dec 31, 2024 $1.08B
Sga Expense restated FY 2025 · Dec 31, 2023 $1B
Net Income FY 2025 · Dec 31, 2025 −$1.1B
Net Income FY 2025 · Dec 31, 2024 −$362.69M
Net Income FY 2025 · Dec 31, 2023 −$41.3M
Operating Income FY 2025 · Dec 31, 2025 $27.46M
Operating Income restated FY 2025 · Dec 31, 2024 −$217.73M
Operating Income restated FY 2025 · Dec 31, 2023 $133.23M
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.47B
Cost Of Revenue restated FY 2025 · Dec 31, 2024 $1.4B
Cost Of Revenue restated FY 2025 · Dec 31, 2023 $1.34B
Revenue FY 2025 · Dec 31, 2025 $2.76B
Revenue restated FY 2025 · Dec 31, 2024 $2.68B
Revenue restated FY 2025 · Dec 31, 2023 $2.55B